05 Nov 2026
Blue Jet Healthcare's Q2 profit roughly doubled to Rs 102.5 crore as revenue rose 127% to Rs 375.7 crore.
EBITDA more than doubled to Rs 118.8 crore at a 32% margin, and the company has completed an Rs 800 crore QIP.
Every Finvezto stock note on Blue Jet Healthcare, dated and newest first. Coverage spans pharma.
Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Past performance is not a guarantee of future results.